2024 Accreditation

Accreditation information for the 2025 course is not yet available.

In support of improving patient care, Harvard Medical School is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

The Harvard Medical School designates this live activity for a maximum of 27.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Risk Management

This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 5.25 credits of Risk Management Study. This includes:

  • 1.00 credits of End-of-Life Care Education
  • 0.50 credits of Medical Marijuana Training
  • 1.75 credits of Opioid Education and Pain Management Training

Please check your individual state licensing board requirements before claiming these credits.

Nurse Practitioners and Registered Nurses

Harvard Medical School is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This activity is approved for 27.75 contact hours, of which 11.00 is eligible for pharmacology credit.

Canadian Accreditation

The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

European Accreditation

The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Additional information regarding this agreement may be found on the American Medical Association (AMA) website.

Jointly Accredited Provider logo from the ACCME.

  • Disclosure Policy

    In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education (ACCME), course planners, speakers, and content reviewers have been asked to disclose any relationships they have to companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

  • Disclaimer

    CME activities accredited by Harvard Medical School are offered solely for educational purposes and do not constitute any form of certification of competency. Practitioners should always consult additional sources of information and exercise their best professional judgment before making clinical decisions of any kind.

    Note: AMA PRA Category 1 Credit™ is calculated based on submission of a preliminary agenda and may be subject to change.

Register Now